Jaeb Center for Health Research
Tampa, Florida, 33647, United States
Location status: Recruiting
NCT Number: NCT07356089
The goal of this surveillance study is to collect real-world data on adults and youth with type 1 diabetes (T1D) using twiist(TM) for insulin delivery.
Interested in participating?
Request Info6 year and older
All sexes
Observational
Tampa, Florida, 33647, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
twiist(TM) system includes a novel insulin pump, a CGM sensor, and the glycemic-control algorithm
Time frame: From enrollment to the end of participation at 12 months
Severe hypoglycemia events with cognitive impairment sufficient to require the assistance of a third party for treatment
Time frame: From enrollment to the end of participation at 12 months
Time frame: From enrollment to the end of participation at 12 months
Time frame: From enrollment to the end of participation at 12 months
Time frame: From enrollment to the end of participation at 12 months
Deka Research and Development
Industry
Twiist Postmarket Surveillance Study in Adults and Youth With Type 1 Diabetes
Acronym: twiist-PS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06919354
Autoimmune Diseases, Diabetes Mellitus
Duarte, California, United States
View Trial DetailsNCT06575426
Autoimmune Diseases, Diabetes Mellitus
Chicago, Illinois, United States
View Trial DetailsNCT07463209
Autoimmune Diseases, Diabetes (DM)
Chapel Hill, North Carolina, United States
View Trial DetailsNCT06752369
Autoimmune Diseases, Behavior
Orlando, Florida, United States
View Trial Details